Kumquat and Bayer Enter $1.3 Billion Global License for KRAS G12D Inhibitor

Leila Ahmed North America Legal Chronicle
Tagged:

Wilson Sonsini Goodrich & Rosati has advised Kumquat Biosciences Inc., and Baker McKenzie advised Bayer. Kumquat Biosciences Inc., a clinical-stage biotechnology company focused on oncology, has…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here
  Share:

Author: Leila Ahmed

…

Membership Required

You must be a member to access this content.

View Membership Levels

Already a member? Log in here